Flex Pharma, Inc.·4

Jul 27, 8:52 AM ET

McVicar William K. 4

4 · Flex Pharma, Inc. · Filed Jul 27, 2017

Insider Transaction Report

Form 4
Period: 2017-07-26
McVicar William K.
President, R&D
Transactions
  • Award

    Stock Option (right to buy)

    2017-07-26+50,00050,000 total
    Exercise: $4.08Exp: 2027-07-26Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The stock option will vest in 48 successive equal monthly installments measured from July 3, 2017.

Documents

2 files